← Back to Search

Topical Retinoid

Topical Acne Medications for Acne

Q: To what demographic is participation in this research open?

The enrollment for this trial requires 72 adults aged 18 to 85 with a current diagnosis of <a href="https://www.withpower.com/clinical-trials/acne">acne</a>. In addition, participants must be US residents and proficient in English.

Q: Are any new participants being sought for this medical study?

The clinical trial database does not list this medical study as currently being open to participants. Initially posted on December 1st 2022, the most recent update was recorded in October of that same year. Despite no longer seeking patients for this particular experiment, there are presently 37 other studies searching for volunteers.

Q: Could individuals who are 35 years or older participate in this research?

To qualify for this trial, applicants must be between 18 and 85 years old. An additional 17 studies are available to minors while individuals over 65 have access to an extra 18 trials.

Phase < 1

Waitlist Available

Led By Steven R Feldman, MD, PhD

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients with a current diagnosis of acne

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up end of study visit - day 56

Awards & highlights

Study Summary

This trial found that acne patients often don't take medications as prescribed, leading to treatment failure, increased healthcare costs & lower quality of life.

Who is the study for?

This trial is for adults over 18 living in the US with a current acne diagnosis who can communicate well in English. It's not for those without an acne diagnosis, under 18, non-US residents, or those who don't speak English sufficiently.Check my eligibility

What is being tested?

The study tests daily use of adapalene gel alone and combined with benzoyl peroxide/clindamycin phosphate gel to treat acne. The goal is to see which treatment works better and how patients stick with them.See study design

What are the potential side effects?

Possible side effects include skin irritation, dryness, redness, peeling at the application site. Some may experience allergic reactions or increased sensitivity to sunlight.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am currently diagnosed with acne.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ end of study visit - day 56

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~end of study visit - day 56

This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study visit - day 56 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Medication Adherence

Secondary outcome measures

Gender specific adherence (female subjects)

Gender specific adherence (male subjects)

Trial Design

3Treatment groups

Experimental Treatment

Group I: Two gel treatmentExperimental Treatment1 Intervention

One-third of the participants will be instructed to apply adapalene and the clindamycin phosphate/benzoyl peroxide gel every day.

Group II: Three gel treatmentExperimental Treatment1 Intervention

One-third of the participants will be instructed to apply adapalene, benzoyl peroxide gel, and clindamycin phosphate gel every day.

Group III: One gel treatmentExperimental Treatment1 Intervention

Every participant will be instructed to apply a topical retinoid every day.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Adapalene Gel

2018

Completed Phase 4

~1650

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

1,241 Previous Clinical Trials

1,004,165 Total Patients Enrolled

Bausch Health Americas, Inc.Industry Sponsor

262 Previous Clinical Trials

81,956 Total Patients Enrolled

6 Trials studying Acne

2,226 Patients Enrolled for Acne

Steven R Feldman, MD, PhDPrincipal InvestigatorWake Forest University Health Sciences

14 Previous Clinical Trials

531 Total Patients Enrolled

Media Library

Adapalene Gel (Topical Retinoid) Clinical Trial Eligibility Overview. Trial Name: NCT05582434 — Phase < 1

Acne Research Study Groups: One gel treatment, Two gel treatment, Three gel treatment

Acne Clinical Trial 2023: Adapalene Gel Highlights & Side Effects. Trial Name: NCT05582434 — Phase < 1

Adapalene Gel (Topical Retinoid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05582434 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what demographic is participation in this research open?

"The enrollment for this trial requires 72 adults aged 18 to 85 with a current diagnosis of acne. In addition, participants must be US residents and proficient in English."

Answered by AI

Are any new participants being sought for this medical study?

"The clinical trial database does not list this medical study as currently being open to participants. Initially posted on December 1st 2022, the most recent update was recorded in October of that same year. Despite no longer seeking patients for this particular experiment, there are presently 37 other studies searching for volunteers."

Answered by AI

Could individuals who are 35 years or older participate in this research?

"To qualify for this trial, applicants must be between 18 and 85 years old. An additional 17 studies are available to minors while individuals over 65 have access to an extra 18 trials."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Experience With Topical Acne Treatment

2024. "Experience With Topical Acne Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05582434.

All > Acne